Trial Outcomes & Findings for Decision Aids for Patients With Nonvalvular Chronic Atrial Fibrillation (DA4AFib) (NCT NCT03744936)
NCT ID: NCT03744936
Last Updated: 2025-01-24
Results Overview
The number of subjects to complete the interview process
Recruitment status
COMPLETED
Target enrollment
34 participants
Primary outcome timeframe
baseline
Results posted on
2025-01-24
Participant Flow
Participant milestones
| Measure |
Nonvalvular Chronic Atrial Fibrillation (DA4AFib)
Subjects who were scheduled for Nonvalvular Chronic Atrial Fibrillation (DA4AFib) treatment at Mayo Clinic Rochester and Mayo Clinic Health System sites in Minnesota
Study team members conducted interviews with subjects to gather feedback on Atrial Fibrillation experiences
|
|---|---|
|
Overall Study
STARTED
|
34
|
|
Overall Study
COMPLETED
|
34
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Decision Aids for Patients With Nonvalvular Chronic Atrial Fibrillation (DA4AFib)
Baseline characteristics by cohort
| Measure |
Nonvalvular Chronic Atrial Fibrillation (DA4AFib)
n=34 Participants
Subjects who were scheduled for Nonvalvular Chronic Atrial Fibrillation (DA4AFib) treatment at Mayo Clinic Rochester and Mayo Clinic Health System sites in Minnesota
Study team members conducted interviews with subjects to gather feedback on Atrial Fibrillation experiences
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
21 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
13 Participants
n=5 Participants
|
|
Age, Continuous
|
50 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
24 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
33 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
34 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: baselineThe number of subjects to complete the interview process
Outcome measures
| Measure |
Nonvalvular Chronic Atrial Fibrillation (DA4AFib)
n=34 Participants
Subjects who were scheduled for Nonvalvular Chronic Atrial Fibrillation (DA4AFib) treatment at Mayo Clinic Rochester and Mayo Clinic Health System sites in Minnesota
Study team members conducted interviews with subjects to gather feedback on Atrial Fibrillation experiences
|
|---|---|
|
Interview Process
|
34 Participants
|
Adverse Events
Nonvalvular Chronic Atrial Fibrillation (DA4AFib)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place